1,2,3,4-tetrahydro-2,8-naphthalenediol | 143325-88-6

• 分子结构分类: 有机化合物 - 苯类化合物 - 四氢化萘
• 英文名称: 1,2,3,4-tetrahydro-2,8-naphthalenediol
• 英文别名: 8-hydroxy-2-tetralol；5,6,7,8-tetrahydronaphthalene-1,7-diol；3,5-dihydroxy-1,2,3,4-tetrahydronaphthalene
• CAS: 143325-88-6；35850-02-3
• 化学式: C₁₀H₁₂O₂
• 分子量: 164.204
• InChiKey: LNLGJFLOBBEUPK-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  1.6
• 重原子数：
  12
• 可旋转键数：
  0
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.4
• 拓扑面积：
  40.5
• 氢给体数：
  2
• 氢受体数：
  2

反应信息

• 作为反应物：
  描述：

  1,2,3,4-tetrahydro-2,8-naphthalenediol 在 氢氧化钾 、 iron(II) chloride 、 维生素 C 作用下， 以 甲醇 、 水 为溶剂， 反应 21.0h， 生成 5-methoxy-1,2,3,4-tetrahydro-2-naphthol
  参考文献：
  名称：

  The Synthesis and Identification of Isomeric Products of Enzymatic O-Demethylation of the Sympathomimetic Tetraminol - trans-3(2-Hydroxyethylamino)-5,8-dimethoxy-1,2,3,4-tetrahydro-2-naphthol

  摘要：

  单-O-去甲基代谢产物的位置异构体（V和VI）的结构已确定，这些代谢产物是Tetraminol - trans-3-(2-羟乙基氨基)-5,8-二甲氧基-1,2,3,4-四氢-2-萘酚（XIX）及其相关衍生物的成对产物。

  DOI：

  10.1135/cccc19921111
• 作为产物：
  描述：

  5,8-dihydro-1-naphthyl acetate 在 lithium aluminium tetrahydride 、 单过氧邻苯二甲酸 作用下， 以 乙醚 为溶剂， 反应 169.0h， 生成 1,2,3,4-tetrahydro-2,8-naphthalenediol
  参考文献：
  名称：

  The Synthesis and Identification of Isomeric Products of Enzymatic O-Demethylation of the Sympathomimetic Tetraminol - trans-3(2-Hydroxyethylamino)-5,8-dimethoxy-1,2,3,4-tetrahydro-2-naphthol

  摘要：

  单-O-去甲基代谢产物的位置异构体（V和VI）的结构已确定，这些代谢产物是Tetraminol - trans-3-(2-羟乙基氨基)-5,8-二甲氧基-1,2,3,4-四氢-2-萘酚（XIX）及其相关衍生物的成对产物。

  DOI：

  10.1135/cccc19921111

文献信息

• Tetrahydroxynaphthalene Reductase: Catalytic Properties of an Enzyme Involved in Reductive Asymmetric Naphthol Dearomatization
  作者：Michael A. Schätzle、Stephan Flemming、Syed Masood Husain、Michael Richter、Stefan Günther、Michael Müller

  DOI：10.1002/anie.201107695

  日期：2012.3.12

  In reduced circumstances: Tetrahydroxynaphthalene reductase shows a broad substrate range including alternate phenolic compounds and cyclic ketones. Structural modeling reveals major enzyme–substrate interactions; C‐terminal truncation of the enzyme causes an altered substrate preference, in accordance with stabilization of the substrate by the C‐terminal carboxylate (see picture). This effect allows

  在减少的情况下：四羟基萘还原酶具有广泛的底物范围，包括其他酚类化合物和环状酮。结构建模揭示了主要的酶-底物相互作用；酶的C末端截短会导致底物偏好发生变化，这取决于C末端羧酸盐对底物的稳定作用（参见图片）。该作用允许鉴定同源酶。
• Vanilloid receptor ligands and their use in treatments
  申请人：Norman H. Mark

  公开号：US20060160872A1

  公开（公告）日：2006-07-20

  Substituted benzimidazoles and compositions containing them, for the treatment of acute, inflammatory and neuropathic pain, dental pain, general headache, migraine, cluster headache, mixed-vascular and non-vascular syndromes, tension headache, general inflammation, arthritis, rheumatic diseases, osteoarthritis, inflammatory bowel disorders, inflammatory eye disorders, inflammatory or unstable bladder disorders, psoriasis, skin complaints with inflammatory components, chronic inflammatory conditions, inflammatory pain and associated hyperalgesia and allodynia, neuropathic pain and associated hyperalgesia and allodynia, diabetic neuropathy pain, causalgia, sympathetically maintained pain, deafferentation syndromes, asthma, epithelial tissue damage or dysfunction, herpes simplex, disturbances of visceral motility at respiratory, genitourinary, gastrointestinal or vascular regions, wounds, burns, allergic skin reactions, pruritus, vitiligo, general gastrointestinal disorders, gastric ulceration, duodenal ulcers, diarrhea, gastric lesions induced by necrotising agents, hair growth, vasomotor or allergic rhinitis, bronchial disorders or bladder disorders.

  含有取代苯并咪唑的组合物，用于治疗急性、炎症性和神经痛、牙痛、普通头痛、偏头痛、集群头痛、混合血管和非血管综合症、紧张性头痛、普通炎症、关节炎、风湿性疾病、骨关节炎、炎症性肠病、炎症性眼疾、炎症性或不稳定的膀胱疾病、银屑病、具有炎症成分的皮肤疾病、慢性炎症疾病、炎症性疼痛及相关的过敏症和痛觉过敏、神经痛及相关的过敏症和痛觉过敏、糖尿病性神经病疼痛、创伤性神经痛、交感神经维持的疼痛、去神经症候群、哮喘、上皮组织损伤或功能障碍、单纯疱疹、呼吸道、泌尿生殖系统、胃肠道或血管区域的内脏运动障碍、伤口、烧伤、过敏性皮肤反应、瘙痒、白癜风、普通胃肠道疾病、胃溃疡、十二指肠溃疡、腹泻、坏死性剂引起的胃病变、毛发生长、血管运动或过敏性鼻炎、支气管疾病或膀胱疾病。
• Benzo[d]imidazol analogs as vanilloid receptor ligands and their use in treatments
  申请人：Amgen Inc.

  公开号：US07429608B2

  公开（公告）日：2008-09-30

  Substituted benzimidazoles and compositions containing them, for the treatment of acute, inflammatory and neuropathic pain, dental pain, general headache, migraine, cluster headache, mixed-vascular and non-vascular syndromes, tension headache, general inflammation, arthritis, rheumatic diseases, osteoarthritis, inflammatory bowel disorders, inflammatory eye disorders, inflammatory or unstable bladder disorders, psoriasis, skin complaints with inflammatory components, chronic inflammatory conditions, inflammatory pain and associated hyperalgesia and allodynia, neuropathic pain and associated hyperalgesia and allodynia, diabetic neuropathy pain, causalgia, sympathetically maintained pain, deafferentation syndromes, asthma, epithelial tissue damage or dysfunction, herpes simplex, disturbances of visceral motility at respiratory, genitourinary, gastrointestinal or vascular regions, wounds, burns, allergic skin reactions, pruritus, vitiligo, general gastrointestinal disorders, gastric ulceration, duodenal ulcers, diarrhea, gastric lesions induced by necrotising agents, hair growth, vasomotor or allergic rhinitis, bronchial disorders or bladder disorders.

  含有取代苯并咪唑的化合物和组合物，用于治疗急性、炎症性和神经性疼痛、牙痛、普通头痛、偏头痛、集群头痛、混合血管和非血管综合症、紧张性头痛、一般性炎症、关节炎、风湿性疾病、骨关节炎、炎症性肠病、炎症性眼病、炎症性或不稳定膀胱疾病、牛皮癣、有炎症成分的皮肤问题、慢性炎症状况、炎症性疼痛和相关的高敏性和触痛、神经性疼痛和相关的高敏性和触痛、糖尿病神经病痛、烧伤后疼痛、交感神经维持疼痛、去神经症候群、哮喘、上皮组织损伤或功能障碍、单纯疱疹、呼吸道、泌尿生殖系统、胃肠道或血管区域内脏运动的障碍、创伤、烧伤、过敏性皮肤反应、瘙痒、白癜风、一般性胃肠道疾病、胃溃疡、十二指肠溃疡、腹泻、坏死性剂引起的胃溃疡性病变、毛发生长、血管运动或过敏性鼻炎、支气管疾病或膀胱疾病。
• Nondepressant .beta.-adrenergic blocking agents. 1. Substituted 3-amino-1-(5,6,7,8-tetrahydro-1-naphthoxy)-2-propanols
  作者：Michael E. Condon、Christopher M. Cimarusti、Rita Fox、V. L. Narayanan、Joyce Reid、Joseph E. Sundeen、Fred P. Hauck

  DOI：10.1021/jm00207a014

  日期：1978.9

  A series of 3-amino-1-(5,6,7,8-tetrahydronaphthoxy)-2-propanols was synthesized and investigated for beta-adrenergic blocking activity and direct myocardial depressant action. The cis- and trans-diols 12--15 were found to retain the beta-blocking potency of propranolol but to lack its myocardial depressant action. Compound 15 (nadolol) is currently undergoing extensive clinical evaluation as a potential antianginal, antiarrhythmic, and antihypertensive agent.
• Enzymatic resolution of 5-hydroxy- and 8-hydroxy-2-tetralols using immobilized lipases
  作者：Paolo Bonomi、Paola Cairoli、Daniela Ubiali、Carlo F. Morelli、Marco Filice、Ines Nieto、Massimo Pregnolato、Paolo Manitto、Marco Terreni、Giovanna Speranza

  DOI：10.1016/j.tetasy.2009.02.011

  日期：2009.3

  (R)-2-Tetralol (R)-2a, (R)-5-hydroxy-2-tetralol (R)-2b and (R)-8-hydroxy-2-tetralol (R)-2c, which are key intermediates in the synthesis of pharmacologically active 2-aminotetralins 3, were prepared in moderate to very high enantiomeric excess (up to 99% ee) by enzymatic resolution of the corresponding racemic butyrates rac-1a, rac-1b and rac-1c, respectively, using lipases immobilized on octyl agarose. This methodology is an alternative to the microbial reduction of 2-tetralones. (c) 2009 Elsevier Ltd. All rights reserved.